Wikipedia:WikiProject Chemicals/Chembox validation/VerifiedDataSandbox and Pentetic acid: Difference between pages

{{Short description|DTPA: aminopolycarboxylic acid}}

{{For|the combined diphtheria-tetanus-acellular pertussis vaccine used in Australia|DTPa}}

{{Chembox

| Watchedfields = changed

| verifiedrevid = 476998825

| IUPACName = ''N'',''N''′-<nowiki/>{[(Carboxymethyl)azanediyl]di(ethane-2,1-diyl)}bis[''N''-(carboxymethyl)glycine]

| SystematicName = 2,2′,2′′,2′′′-<nowiki/>{[(Carboxymethyl)azanediyl]bis(ethane-2,1-diylnitrilo)}tetraacetic acid

| OtherNames = DTPA; H₅dtpa; Diethylenetriaminepentaacetic acid; Penta(carboxymethyl)diethylenetriamine<ref>Anonymous Pentetic Acid. In Dictionary of Organic Compounds, Sixth Edition; Buckingham, J., Macdonald, F., Eds.; CRC Press: 1996; Vol. 5, pp 1188.</ref>

|Section1={{Chembox Identifiers

| UNII_Ref = {{fdacite|changed|FDA}}

| UNII = 7A314HQM0I

|Section2={{Chembox Properties

| C=14 | H=23 | N=3 | O=10

| pKa = ~1.80 (20 °C) <ref>Moeller, T.; Thompson, L. C. Observations on the rare earths—LXXV(1): The stabilities of diethylenetriaminepentaacetic acid chelates. Journal of Inorganic and Nuclear Chemistry 1962, 24, 499.</ref>

|Section3={{Chembox Structure

|Section7={{Chembox Hazards

| ExternalSDS =

| FlashPt = Non-flammable

| HPhrases =

| PPhrases =

| GHS_ref =

|Section8={{Chembox Related

| OtherCompounds = [[EDTA]], [[Nitrilotriacetic acid|NTA]]

'''Pentetic acid''' or '''diethylenetriaminepentaacetic acid''' ('''DTPA''') is an [[aminopolycarboxylic acid]] consisting of a [[diethylenetriamine]] backbone with five carboxymethyl groups. The molecule can be viewed as an expanded version of [[Ethylenediaminetetraacetic acid|EDTA]] and is used similarly. It is a white solid with limited solubility in water.

==Coordination properties==

The [[Conjugate acid|conjugate base]] of DTPA has a high affinity for metal [[cations]]. Thus, the penta-anion DTPA⁵⁻ is potentially an [[denticity|octadentate ligand]] assuming that each nitrogen centre and each –COO⁻ group counts as a centre for coordination. The [[Stability constants of complexes|formation constants]] for its complexes are about 100 greater than those for EDTA.<ref name=Ullmann>J. Roger Hart "Ethylenediaminetetraacetic Acid and Related Chelating Agents" in Ullmann's Encyclopedia of Industrial Chemistry, Wiley-VCH, Weinheim, 2005.{{doi|10.1002/14356007.a10_095}}</ref> As a [[Chelation|chelating agent]], DTPA wraps around a metal ion by forming up to eight bonds. Its complexes can also have an extra water molecule that coordinates the metal ion.<ref name="ReferenceA">{{Cite journal|last1=Deblonde|first1=Gauthier J.-P.|last2=Kelley|first2=Morgan P.|last3=Su|first3=Jing|last4=Batista|first4=Enrique R.|last5=Yang|first5=Ping|last6=Booth|first6=Corwin H.|last7=Abergel|first7=Rebecca J.|date=2018|title=Spectroscopic and Computational Characterization of Diethylenetriaminepentaacetic Acid/Transplutonium Chelates: Evidencing Heterogeneity in the Heavy Actinide(III) Series|journal=Angewandte Chemie International Edition|language=en|volume=57|issue=17|pages=4521–4526|doi=10.1002/anie.201709183|pmid=29473263|osti=1426318|issn=1521-3773|doi-access=free}}</ref> Transition metals, however, usually form less than eight [[Dipolar bond|coordination bonds]]. So, after forming a complex with a metal, DTPA still has the ability to bind to other reagents, as is shown by its derivative [[pendetide]]. For example, in its complex with copper(II), DTPA binds in a hexadentate manner utilizing the three amine centres and three of the five carboxylates.<ref>V. V. Fomenko, T. N. Polynova, M. A. Porai-Koshits, G. L. Varlamova and N. I. Pechurova ''Crystal structure of copper (II) diethylenetriaminepentaacetate monohydrate'' Journal of Structural Chemistry, 1973, Vol. 14, 529. {{doi|10.1007/BF00747020}}</ref>

==Chelating applications==

Like the more common [[Ethylenediaminetetraacetic acid|EDTA]], DTPA is predominantly used as [[Chelation|chelating]] agent for complexing and [[sequestering agent|sequestering]] metal ions.

DTPA has been considered for treatment of radioactive materials such as [[plutonium]], [[americium]], and other [[actinide]]s.<ref name="ReferenceA"/> In theory, these complexes are more apt to be eliminated in [[urine]]. It is normally administered as the [[calcium]] or [[zinc]] salt (Ca or Zn-DTPA), since these ions are readily displaced by more highly charged cations and mainly to avoid to depleting them in the organism. DTPA forms complexes with [[thorium]](IV), [[uranium]](IV), [[neptunium]](IV), and [[cerium]](III/IV).<ref>(2) Brown, M. A.; Paulenova, A.; Gelis, A. V. "Aqueous Complexation of Thorium(IV), Uranium(IV), Neptunium(IV), Plutonium(III/IV), and Cerium(III/IV) with DTPA" Inorganic Chemistry 2012, volume 51, 7741-7748. {{doi|10.1021/ic300757k}}</ref>

In August, 2004 the [[Food and Drug Administration|US Food and Drug Administration]] (USFDA) determined zinc-DTPA and calcium-DTPA to be safe and effective for treatment of those who have breathed in or otherwise been contaminated internally by plutonium, americium, or curium. The recommended treatment is for an initial dose of calcium-DTPA, as this salt of DTPA has been shown to be more effective in the first 24 hours after internal contamination by plutonium, americium, or curium. After that time has elapsed both calcium-DTPA and zinc-DTPA are similarly effective in reducing internal contamination with [[plutonium]], [[americium]] or [[curium]], and zinc-DTPA is less likely to deplete the body's normal levels of zinc and other metals essential to health. Each drug can be administered by [[nebulizer]] for those who have breathed in contamination, and by [[Intravenous therapy|intravenous injection]] for those contaminated by other routes.<ref name="USFDA">{{cite web | url=https://www.fda.gov/Drugs/EmergencyPreparedness/BioterrorismandDrugPreparedness/ucm130312.htm | title="FDA Approves Drugs to Treat Internal Contamination from Radioactive Elements" (press release) | publisher=United States Food and Drug Administration | orig-year=4 August 2004| date=19 June 2015 | access-date=2 August 2016}}</ref>

DTPA is also used as [[Magnetic resonance imaging|MRI]] [[Contrast agent|contrasting agent]]. DTPA improves the resolution of magnetic resonance imaging (MRI) by forming a soluble complex with a [[gadolinium]] (Gd³⁺) ion, which alters the [[magnetic resonance]] behavior of the [[proton]]s of the nearby [[Properties of water|water molecules]] and increases the images contrast.<ref>Caravan, Peter; Ellison, Jeffrey J.; McMurry, Thomas J. ; Lauffer, Randall B. "Gadolinium(III) Chelates as MRI Contrast Agents:  Structure, Dynamics, and Applications" Chem. Revs. 1999, volume 99, pp. 2293–2342.</ref>

DTPA under the form of iron(II) chelate (Fe-DTPA, 10 – 11 wt. %) is also used as [[Aquascaping|aquarium plants]] [[fertilizer]]. The more soluble form of iron, Fe(II), is a [[micronutrient]] needed by [[aquatic plant]]s. By binding to Fe²⁺ ions DTPA prevents their [[Precipitation (chemistry)|precipitation]] as Fe(OH)₃, or Fe₂O₃ · n H₂O poorly soluble oxy-hydroxides after their [[Redox|oxidation]] by dissolved [[oxygen]]. It increases the [[solubility]] of Fe²⁺ and Fe³⁺ ions in water, and therefore the [[bioavailability]] of iron for aquatic plants. It contributes so to maintain iron under a dissolved form (probably a mix of Fe(II) and Fe(III) DTPA complexes) in the [[water column]]. It is unclear to what extent does DTPA really contribute to protect dissolved Fe²⁺ against air oxidation and if the Fe(III)-DTPA complex cannot also be directly assimilated by aquatic plants simply because of its enhanced solubility. Under natural conditions, ''i.e.'', in the absence of complexing DTPA, Fe²⁺ is more easily assimilated by most organisms, because of its 100-fold higher solubility than that of Fe³⁺.

In [[pulp mill|pulp and paper mills]] DTPA is also used to remove dissolved ferrous and ferric ions (and other redox-active metal ions, such as [[manganese|Mn]] or [[copper|Cu]]) that otherwise would accelerate the [[Catalysis|catalytic]] decomposition of [[hydrogen peroxide]] (H₂O₂ reduction by Fe²⁺ ions according to the [[Fenton's reagent|Fenton reaction]] mechanism).<ref name="Cohen_1981">{{cite journal|last1=Cohen|first1=Gerald|last2=Lewis|first2=David|last3=Sinet|first3=Pierre M.|title=Oxygen consumption during the Fenton-type reaction between hydrogen peroxide and a ferrous-chelate (Fe²⁺-DTPA)|journal=Journal of Inorganic Biochemistry|volume=15|issue=2|year=1981|pages=143–151|issn=0162-0134|doi=10.1016/S0162-0134(00)80298-6}}</ref> This helps preserving the [[Redox|oxidation]] capacity of the hydrogen peroxide stock which is used as [[oxidizing agent]] to [[bleaching of wood pulp|bleach pulp]] in the chlorine-free process of paper making.<ref name="Colodette_1987">Colodette, J. L. (1987). Factors affecting hydrogen peroxide stability in the brightening of mechanical and chemi-mechanical pulps (Doctoral dissertation, State University of New York College of Environmental Science and Forestry).</ref> Several thousands tons of DTPA are produced annually for this purpose in order to limit the non-negligible losses of H₂O₂ by this mechanism.<ref name="Ullmann" />

DTPA chelating properties are also useful in deactivating [[calcium]] and [[magnesium]] ions in [[Hairstyling product|hair products]]. DTPA is used in over 150 cosmetic products.<ref>Burnett, L. C. "Final Report on the Safety Assessment of Pentasodium Pentetate and Pentetic Acid as Used in Cosmetics" International Journal of Toxicology 2008, 27, 71-92.</ref>

==Biochemistry==

DTPA is more effective than [[EDTA]] to deactivate redox-active metal ions such as Fe(II)/(III), Mn(II)/(IV) and Cu(I)/(II) perpetuating [[oxidative damage]]s induced in [[cell (biology)|cell]]s by [[superoxide]] and [[hydrogen peroxide]].<ref name="Fisher_2004">{{cite journal|last1=Fisher|first1=Anna E.O.|last2=Maxwell|first2=Suzette C.|last3=Naughton|first3=Declan P.|title=Superoxide and hydrogen peroxide suppression by metal ions and their EDTA complexes|journal=Biochemical and Biophysical Research Communications|volume=316|issue=1|year=2004|pages=48–51|issn=0006-291X|doi=10.1016/j.bbrc.2004.02.013|pmid=15003509 }}</ref><ref name="Cohen_1981" /> DTPA is also used in [[bioassay]]s involving redox-active metal ions.

==Environmental impact==

An unexpected negative environmental impact of chelating agents, as DTPA, is their toxicity for the [[activated sludge]]s in the treatment of [[Kraft pulping]] effluents.<ref name="Larisch_1997">{{cite journal|last1=Larisch|first1=B.C.|last2=Duff|first2=S.J.B.|title=Effect of H₂O₂ and DTPA on the characteristics and treatment of TCF (totally chlorine-free) and ECF (elementally chlorine-free) kraft pulping effluents|journal=Water Science and Technology|volume=35|issue=2–3|year=1997|issn=0273-1223|doi=10.1016/S0273-1223(96)00928-6|doi-access=}}</ref> Most of the DTPA worldwide production (several thousands of tons)<ref name="Ullmann" /> is intended to avoid [[hydrogen peroxide]] decomposition by redox-active [[iron]] and [[manganese]] ions in the chlorine-free Kraft pulping processes (total chlorine free (TCF) and environmental chlorine free (ECF) processes). DTPA decreases the [[biological oxygen demand]] (BOD) of activated sludges and therefore their microbial activity.

==Related compounds==

Compounds that are structurally related to DTPA are used in medicine, taking advantage of the high affinity of the triaminopentacarboxylate scaffold for metal ions.

*In [[ibritumomab tiuxetan]], the chelator tiuxetan is a modified version of DTPA whose carbon backbone contains an isothiocyanatobenzyl and a [[methyl group]].<ref>{{Cite journal|doi=10.1038/nrd1413|issn=1474-1776|volume=3|issue=6|pages=488–99|last=Milenic|first=Diane E.|author2=Erik D. Brady |author3=Martin W. Brechbiel |title=Antibody-targeted radiation cancer therapy|journal=Nat Rev Drug Discov|date=June 2004|pmid=15173838|s2cid=22166498|url=https://zenodo.org/record/1233515}}</ref>

*In [[Indium (111In) capromab pendetide|capromab pendetide]] and [[Indium (111In) satumomab pendetide|satumomab pendetide]], the chelator [[pendetide]] (GYK-DTPA) is a modified DTPA containing a [[peptide]] linker used to connect the chelate to an [[antibody]].<ref>{{Cite journal|volume=14|issue=2|pages=99–111|last=Kahn|first=Daniel|author2=J. Christopher Austin |author3=Robert T Maguire |author4=Sara J Miller |author5=Jack Gerstbrein |author6=Richard D Williams |title=A Phase II Study of [90Y] Yttrium-Capromab Pendetide in the Treatment of Men with Prostate Cancer Recurrence Following Radical Prostatectomy|journal=Cancer Biotherapy & Radiopharmaceuticals|year=1999|doi=10.1089/cbr.1999.14.99|pmid=10850293}}</ref>

*Pentetreotide is a modified DTPA attached to a [[peptide]] segment.<ref>{{Cite journal|doi=10.1016/j.addr.2008.04.006|issn=0169-409X|volume=60|issue=12|pages=1347–70|last=Liu|first=Shuang|title=Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides|journal=Advanced Drug Delivery Reviews|date=2008-09-15|pmid=18538888|pmc=2539110}}</ref>

*DTPA and derivatives are used to chelate [[gadolinium]] to form an [[Magnetic resonance imaging|MRI]] contrast agent, such as [[Gadopentetic acid|Magnevist]].

*[[Technetium-99m]] is chelated with DTPA for [[Ventilation/perfusion scan|ventilation perfusion (V/Q) scans]] and [[radioisotope renography]] [[nuclear medicine]] scans.<ref>{{cite book|last1=Chowdhury|first1=Rajat|last2=Wilson|first2=Iain|last3=Rofe|first3=Christopher|last4=Lloyd-Jones|first4=Graham|title=Radiology at a Glance|publisher=John Wiley & Sons|isbn=9781118691083|page=109|url=https://books.google.com/books?id=pbMRAAAAQBAJ&pg=PA109|language=en|date=2013-07-08}}</ref>

==See also==

* [[Nuclear medicine]]

* [[Radiopharmaceutical]]

* [[Hydrogen peroxide#Decomposition|Hydrogen peroxide decomposition]]

* [[Bleaching of wood pulp#Chelant wash|DTPA in chlorine-free Kraft pulping]]

==References==

{{reflist}}

:''This article incorporates material from [https://web.archive.org/web/20071103113909/http://www.bt.cdc.gov/radiation/dtpa.asp Facts about DTPA], a [[fact sheet]] produced by the United States [[Centers for Disease Control and Prevention]].

{{Chelating agents}}

[[Category:Chelating agents]]

[[Category:Acetic acids]]

[[Category:Tertiary amines]]

[[Category:Nuclear medicine]]

[[Category:Magnetic resonance imaging]]